Inovio Pharmaceuticals (INO) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Inovio Pharmaceuticals (INO) over the last 14 years, with Q4 2024 value amounting to $16.5 million.
- Inovio Pharmaceuticals' Accumulated Depreciation & Amortization fell 2105.07% to $16.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $16.5 million, marking a year-over-year decrease of 2105.07%. This contributed to the annual value of $16.5 million for FY2024, which is 2105.07% down from last year.
- As of Q4 2024, Inovio Pharmaceuticals' Accumulated Depreciation & Amortization stood at $16.5 million, which was down 2105.07% from $20.9 million recorded in Q4 2023.
- In the past 5 years, Inovio Pharmaceuticals' Accumulated Depreciation & Amortization registered a high of $21.6 million during Q4 2022, and its lowest value of $89000.0 during Q4 2021.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $16.5 million (2024), whereas its average is $11.8 million.
- Per our database at Business Quant, Inovio Pharmaceuticals' Accumulated Depreciation & Amortization crashed by 5550.0% in 2021 and then skyrocketed by 2412854.27% in 2022.
- Inovio Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $200000.0 in 2020, then crashed by 55.5% to $89000.0 in 2021, then soared by 24128.54% to $21.6 million in 2022, then decreased by 3.3% to $20.9 million in 2023, then fell by 21.05% to $16.5 million in 2024.
- Its Accumulated Depreciation & Amortization was $16.5 million in Q4 2024, compared to $20.9 million in Q4 2023 and $21.6 million in Q4 2022.